Treatment of diffuse large B-cell lymphoma with secondary central nervous system involvement: encouraging efficacy using CNS-penetrating R-IDARAM chemotherapy-Reference-Cited by-同舟云学术

Treatment of diffuse large B-cell lymphoma with secondary central nervous system involvement: encouraging efficacy using CNS-penetrating R-IDARAM chemotherapy

Published:2015-12-18 Issue:4 Volume:172 Page:545-553
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Maciocia Paul¹,Badat Mohsin²,Cheesman Simon³,D'Sa Shirley⁴,Joshi Rahul⁴,Lambert Jonathan⁴,Mohamedbhai Sajir¹⁴,Pule Martin¹⁴,Linch David¹⁴,Ardeshna Kirit⁴

Affiliation:

1. Cancer Institute; Department of Haematology; University College London; London UK

2. Department of Haematology; Royal London Hospital; London UK

3. Department of Pharmacy; University College London Hospital; London UK

4. Department of Haematology; University College London Hospital; London UK

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13867/fullpdf

Reference32 articles.

1. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma;Abrey;Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology,2005

2. Schedule-dependent synergism and antagonism between methotrexate and cytarabine against human leukemia cell lines in vitro;Akutsu;Leukemia,2002

3. Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma;Besien;Blood,1998

4. Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma;Bierman;Hematology/Oncology Clinics of North America,2005

5. Clinical results and pharmacokinetics of high-dose cytosine arabinoside (HD ARA-C);Breithaupt;Cancer,1982

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meta-Analysis of MS-Based Proteomics Studies Indicates Interferon Regulatory Factor 4 and Nucleobindin1 as Potential Prognostic and Drug Resistance Biomarkers in Diffuse Large B Cell Lymphoma;Cells;2023-01-03

2. Recurrent diffuse large B-Cell lymphoma with the initial manifestation of retinal involvement;Journal of Cancer Research and Practice;2023

3. The genomic and transcriptional landscape of primary central nervous system lymphoma;Nature Communications;2022-05-10

4. Improving the outcomes of secondary CNS lymphoma with high-dose thiotepa, busulfan, melphalan, rituximab conditioning and autotransplant;Leukemia & Lymphoma;2022-04-22

5. Miliary pattern in secondary central nervous system T-cell lymphoma;Surgical Neurology International;2022-01-20